港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

生物医药B类股

475.823

+15.7943.43%

涨家数：25

跌家数：7

平家数：2

市盈率：- -

高：490.424

开：460.208

低：460.208

收：460.029

数据加载中...

每日卖空追踪 | 康宁杰瑞制药-B 04月22日卖空量成交12.8万股，卖空比例为3.79%

尚博医药 2024 年年度股东大会决议出炉

聚焦肺癌治疗创新药正发力

经济参考报

康哲药业：分拆德镁医药上市潜力有望迎来释放

康方生物：AK112联合化疗一线治疗SQ-NSCLC(VS替雷利珠单抗联用化疗)MPFS取得强阳性结果

药明巨诺-B向Juno授予JW sLVV生产工艺及相关技术知识的非独家许可

药明巨诺-B(02126)向Juno授予JW sLVV生产工艺及相关技术知识的非独家许可

心泰医疗(02291.HK)：股价异动未知悉原因明日复牌

康哲药业(00867)建议分拆德镁医药股份于联交所主板独立上市

创新药大涨，机器人回落

传特朗普再祭药价改革大旗拟推“国际挂钩“政策动医药巨头奶酪

再鼎医药(09688)4月22日发行新股200万股

ETF日报：当前创新药行业正处于技术突破、政策支持、业绩兑现、全球化扩张四重驱动下的景气上行周期

云顶新耀成功＂摘B“ ”双轮驱动“战略进入全新阶段

每日卖空追踪 | 科济药业-B 04月22日卖空量成交87.65万股，卖空比例为16.84%

普京与阿曼苏丹会面双方将探讨多领域合作项目

每日卖空追踪 | 云顶新耀-B 04月22日卖空量成交31万股，卖空比例为5.03%

亿腾医药“借壳”嘉和生物：标的“重营销轻研发”藏隐患

再鼎医药(ZLAB)盘前涨超7% 瑞普替尼新适应症上市申请获受理

消息人士称，特朗普正在考虑将美国药品价格降至国际水平

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1574/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":475.82297,"timestamp":1745395729778,"preClose":460.02872,"halted":0,"volume":182007270,"delay":0,"changeRate":0.034333,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":15.79425,"latestTime":"04-23 16:00:00","open":460.20847,"high":490.42355,"low":460.20847,"amount":4899749813.88,"amplitude":0.065681,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745458200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745371800000,1745380800000],[1745384400000,1745395200000]],"pbRate":3.815088,"peRate":-22.753691,"turnoverRate":0.006853,"increases":25,"decrements":7,"flats":1,"marketCap":273766136640,"floatMarketCap":254028730592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":490.42355,"amplitude":0.065681,"preClose":460.02872,"low":460.20847,"pbRate":"3.815088","latestPrice":475.82297,"volume":182007270,"delay":0,"open":460.20847,"prevYearClose":331.1933,"prevWeekClose":424.614,"prevMonthClose":455.082,"prevQuarterClose":455.082,"fiveDayClose":440.942,"twentyDayClose":428.663,"sixtyDayClose":320.043,"secType":"PLATE","market":"HK","turnoverRate":0.006853,"peRate":-22.753691,"marketCap":273766136640,"floatMarketCap":254028730592,"timestamp":1745395729778,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":25,"down":7,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529524665","title":"每日卖空追踪 | 康宁杰瑞制药-B 04月22日卖空量成交12.8万股，卖空比例为3.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529524665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529524665?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 04:21","pubTimestamp":1745353261,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间04月22日，涨4.98%，卖空量成交12.8万股，较上一交易日减少27.27%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423042105a462e64e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423042105a462e64e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2529155398","title":"尚博医药 2024 年年度股东大会决议出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2529155398","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529155398?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 02:10","pubTimestamp":1745345420,"startTime":"0","endTime":"0","summary":"2025年4月23日，济南尚博医药股份有限公司 2024 年年度股东大会于 2025 年 4 月 21 日在集团二楼大会议室以现场投票的方式召开，由董事长王武宝主持。本次股东大会的通知已于 2025 年 3 月 31 日在全国中小企业股份转让系统网站发布，距本次股东大会的召开日期已超过 20 日。济南尚博医药股份有限公司董事会于 2025 年 4 月 21 日发布相关公告。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/23021049771634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159938","09939","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2529254558","title":"聚焦肺癌治疗 创新药正发力","url":"https://stock-news.laohu8.com/highlight/detail?id=2529254558","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529254558?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 02:01","pubTimestamp":1745344863,"startTime":"0","endTime":"0","summary":"国际癌症研究机构（IARC）2024年发布的数据显示，肺癌是2022年全球范围内新增发病率和死亡率最高的癌种。在我国，肺癌发生率和死亡率长期居于高位。在第31个全国肿瘤防治宣传周期间，围绕肺癌防治的相关话题，记者采访了业内专家。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504233384844923.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504233384844923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","06978"],"gpt_icon":0},{"id":"2529996305","title":"康哲药业：分拆德镁医药上市 潜力有望迎来释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2529996305","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529996305?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 00:00","pubTimestamp":1745337600,"startTime":"0","endTime":"0","summary":"公司近况4 月22 日晚，公司公告建议分拆子公司德镁医药于港交所主板独立上市，分拆建议仍需取决于相关部门批准、公司董事会以及德镁医药董事会批准。根据公告，建议分拆（若进行）采用实物方式向股东分派其持有所有德镁医药股份方式实施，股东享有的德镁医药股权不会被稀释。目前德镁医药90.8%股权由康哲药业持有，9.2%股权由两个员工激励平台持有。分拆完成上市后，康哲药业与德镁医药将各自拥有独立上市地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423090620a6c475ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423090620a6c475ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00867","LU2488822045.USD","BK1191","IE00BYV24P56.USD","BK1161","IE00BMCWC346.EUR","09939","SG9999015945.SGD","SG9999015952.SGD","SG9999015978.USD","SG9999004220.SGD","BK1593","SG9999015986.USD","BK1515","BK1574"],"gpt_icon":0},{"id":"2529542640","title":"康方生物：AK112联合化疗一线治疗SQ-NSCLC(VS替雷利珠单抗联用化疗)MPFS取得强阳性结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2529542640","media":"中金公司","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529542640?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 00:00","pubTimestamp":1745337600,"startTime":"0","endTime":"0","summary":"公司近况4 月23 日，公司宣布AK112 联合化疗对比替雷利珠单抗联合化疗用于治疗1L sqNSCLC的注册性III期临床期中分析达到主要终点。在PD-L1 阳性及阴性人群中，均显示出PFS明显获益。参考AK112+化疗的II期临床，以及替雷利珠单抗+化疗的III期临床，我们预计AK112-306 临床最终mPFS表现较好。AK112 在NSCLC领域已有3 个显著阳性结果的III期临床研究，进一步增加了海外临床的确定性，我们预计AK112 在肺癌领域的国内外销售空间有望进一步打开。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423150620a6c4cac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423150620a6c4cac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","BK1161","LU0348784397.USD","LU1720050803.USD","IE00B543WZ88.USD","LU0348783233.USD","LU0417516571.SGD","LU2488822045.USD","09926","LU1794554557.SGD"],"gpt_icon":0},{"id":"2529314535","title":"药明巨诺-B向Juno授予JW sLVV生产工艺及相关技术知识的非独家许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2529314535","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529314535?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 23:36","pubTimestamp":1745336160,"startTime":"0","endTime":"0","summary":"药明巨诺-B(02126)公布，公司已与公司主要股东之一及关联人士Juno于202...药明巨诺-B(02126)公布，公司已与公司主要股东之一及关联人士Juno于2025年 4月18日(东部时间)订立许可协议，据此，公司向Juno授予JW sLVV生产工艺及相关技术知识(以及专利，若在该许可协议有效期内的任何时间适用)的非独家许可，该等技术知识主要或直接与Juno细胞治疗产品的在全球领域中开发、商业化、制造或委托制造相关，或就其而言属合理必要或有用。 Juno根据许可协议应付公司的代价总价值将不超过1000万美元。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422233913a462a665&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422233913a462a665&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1161","02126"],"gpt_icon":0},{"id":"2529538813","title":"药明巨诺-B(02126)向Juno授予JW sLVV生产工艺及相关技术知识的非独家许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2529538813","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529538813?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 22:52","pubTimestamp":1745333548,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明巨诺-B(02126)公布，公司已与公司主要股东之一及关联人士Juno于2025年 4月18日(东部时间)订立许可协议，据此，公司向Juno授予JW sLVV生产工艺及相关技术知识(以及专利，若在该许可协议有效期内的任何时间适用)的非独家许可，该等技术知识主要或直接与Juno细胞治疗产品的在全球领域中开发、商业化、制造或委托制造相关，或就其而言属合理必要或有用。 Juno根据许可协议应付公司的代价总价值将不超过1000万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1583","BK1161","02126"],"gpt_icon":0},{"id":"2529582438","title":"心泰医疗(02291.HK)：股价异动未知悉原因 明日复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2529582438","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529582438?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 22:21","pubTimestamp":1745331690,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1574","02291","BK1100","161027","09996","BK1583","159883","09997","BK1222"],"gpt_icon":0},{"id":"2529585619","title":"康哲药业(00867)建议分拆德镁医药股份于联交所主板独立上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529585619","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529585619?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 21:36","pubTimestamp":1745329000,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 公布，公司建议将公司附属公司德镁医药股份分拆并于联交所主板独立上市。建议分拆(倘进行)预计将透过由公司以实物方式向股东分派其持有的所有德镁医药股份的方式实施，分派比例将按截至董事会为确定股东权利而厘定的记录日期当日彼等各自于公司的持股比例计算。联交所已确认公司可进行建议分拆事宜。据悉，德镁医药是一家在开曼群岛注册成立的获豁免有限公司，为公司的附属公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282603.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00867","09939","BK1574","SG9999004220.SGD","BK1161","SG9999015945.SGD","IE00BMCWC346.EUR","BK1515","SG9999015986.USD","LU2488822045.USD","SG9999015952.SGD","IE00BYV24P56.USD","BK1191","BK1593","159938","SG9999015978.USD"],"gpt_icon":0},{"id":"2529583376","title":"创新药大涨，机器人回落","url":"https://stock-news.laohu8.com/highlight/detail?id=2529583376","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529583376?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 21:09","pubTimestamp":1745327340,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　隔夜美股大跌，三大指数跌幅均超过2%。　　4月22日，A股市场以AI为主的科技股回调，但医药股表现不错。　　受访人士认为，关税战对市场的冲击或将逐步脱敏，在“稳股市”政策托底之下，A股下行空间或有限，短期内维持区间震荡态势。　　医药股大涨，减肥药、创新药概念涨逾2%，昨日大涨的机器人执行器回调2.52%，人形机器人跌近2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-04-22/doc-inetzzst5228925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","06978","BK1574","BK1161"],"gpt_icon":0},{"id":"2529304623","title":"传特朗普再祭药价改革大旗 拟推“国际挂钩“政策动医药巨头奶酪","url":"https://stock-news.laohu8.com/highlight/detail?id=2529304623","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529304623?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 20:41","pubTimestamp":1745325684,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据两位接近决策层的知情人士透露，美国制药行业近日收到白宫警告：特朗普政府正在酝酿重启\"国际参考定价\"计划，拟将美国药品价格与发达国家市场挂钩。消息人士分析，相较于尚在酝酿的药品关税方案，直接引入国际药价参照体系将彻底颠覆美国医药市场定价机制。这场由白宫推动的药价革命，正在全球医药市场引发连锁地震。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1574","09939","BK1515","BK1161"],"gpt_icon":0},{"id":"2529630675","title":"再鼎医药(09688)4月22日发行新股200万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529630675","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529630675?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 20:21","pubTimestamp":1745324463,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，于2025年4月22日因兑现按先前披露的条款(1)归属根据 2017，2022及2024年股权激励计划所授出的非期权奖励，及(2)如适用，行使根据2015，2017，2022及2024年股权激励计划所授出的购股权发行新股200万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282505.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4588","BK1574","BK4526","BK1588","BK1161","BK4531","LU2488822045.USD","09688","ZLAB","BK4548","BK4585"],"gpt_icon":0},{"id":"2529730911","title":"ETF日报：当前创新药行业正处于技术突破、政策支持、业绩兑现、全球化扩张四重驱动下的景气上行周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2529730911","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529730911?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 20:18","pubTimestamp":1745324280,"startTime":"0","endTime":"0","summary":"A股大小指数分化，沪指盘中收复3300点，统一大市场方向领涨，创业板指表现不振，科技股哑火。上证指数收涨0.25%报3299.76点，深证成指跌0.36%，创业板指跌0.82%，北证50跌0.64%，科创50跌0.31%，万得全A跌0.05%，万得A500跌0.09%，中证A500跌0.18%。A股成交1.12万亿，上日为1.07万亿。　　今日，COMEX黄金突破3500美元/盎司，续创历史新高，年内累涨逾30%。避险属性方面，俄乌战争、中东局势紧张及美国关税政策的反复无常加剧了全球市场的不确定性。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-04-22/doc-inetzzss0730349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1161","FDN","BK4585","BK4550","06978","BK4588","159992"],"gpt_icon":0},{"id":"2529530521","title":"云顶新耀成功＂摘B“ ”双轮驱动“战略进入全新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2529530521","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529530521?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 19:58","pubTimestamp":1745323119,"startTime":"0","endTime":"0","summary":"新华财经上海4月22日电（记者胡洁菲）云顶新耀22日宣布已获得香港联交所批准，正式将“B”标记从股票代码中移除。云顶新耀首席执行官罗永庆对此表示，云顶新耀已满足香港联交所常规上市条件，顺利移除“B”标志，实现了公司发展历程中的重要突破。移除“B”标记是18A生物科技公司发展的重要标志，考量的是香港联交所规定的收入、市值等指标，进而反映出公司在产品管线和商业化上的能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504223384603936.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","01952","BK1583","BK1161"],"gpt_icon":0},{"id":"2529309787","title":"每日卖空追踪 | 科济药业-B 04月22日卖空量成交87.65万股，卖空比例为16.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529309787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529309787?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 19:54","pubTimestamp":1745322844,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间04月22日，涨16.17%，卖空量成交87.65万股，较上一交易日增加245.76%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422195412a4626cce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422195412a4626cce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1585","BK1587","02171"],"gpt_icon":0},{"id":"2529377591","title":"普京与阿曼苏丹会面 双方将探讨多领域合作项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2529377591","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529377591?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 19:26","pubTimestamp":1745321167,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["159945","01477","BK1574","BK1191"],"gpt_icon":0},{"id":"2529521377","title":"每日卖空追踪 | 云顶新耀-B 04月22日卖空量成交31万股，卖空比例为5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529521377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529521377?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 19:22","pubTimestamp":1745320969,"startTime":"0","endTime":"0","summary":"云顶新耀-B北京时间04月22日，涨3.61%，卖空量成交31万股，较上一交易日增加2.31%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422192250a6c3b392&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422192250a6c3b392&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01952","BK1583"],"gpt_icon":0},{"id":"2529377602","title":"亿腾医药“借壳”嘉和生物：标的“重营销轻研发”藏隐患","url":"https://stock-news.laohu8.com/highlight/detail?id=2529377602","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529377602?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 19:11","pubTimestamp":1745320281,"startTime":"0","endTime":"0","summary":"近日，嘉和生物（06998）发布申请版本全文档案，公司将通过合并方式收购亿腾医药，合并完成后，原亿腾医药股东将持有嘉和生物本次发行后股份的约77%，而嘉和生物原股东将持有约23%的股份。本次合并亿腾医药将实现“借壳”上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504223384568019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","09939","BK1161","06998","BK1515","BK1583"],"gpt_icon":0},{"id":"2529943371","title":"再鼎医药(ZLAB)盘前涨超7% 瑞普替尼新适应症上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2529943371","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529943371?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 18:52","pubTimestamp":1745319158,"startTime":"0","endTime":"0","summary":"金吾财讯 | 再鼎医药(ZLAB)盘前涨超7%，截至发稿，报31.87美元。消息面上，4月21日，再鼎医药宣布，国家药品监督管理局（NMPA）已受理瑞普替尼（repotrectinib）的补充新药上市申请（sNDA），用于治疗携带神经营养酪氨酸受体激酶（NTRK）基因融合的实体瘤成人患者，该类患者为局部晚期、转移性，或手术切除可能导致严重并发症的患者，且这些患者在接受既往治疗后出现疾病进展，或缺乏有效的治疗方案选择。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/OWU4OGExOTI2NzgyMTc2NjE0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/OWU4OGExOTI2NzgyMTc2NjE0.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"287723","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4139","BK4588","BK4585","09688","BK4526","ZLAB","BK1574","BK4548","LU2488822045.USD","BK1588","BK4531"],"gpt_icon":0},{"id":"2529378322","title":"消息人士称，特朗普正在考虑将美国药品价格降至国际水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2529378322","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529378322?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 18:11","pubTimestamp":1745316703,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159891","BK1574","BK1191","01477"],"gpt_icon":0}],"pageSize":20,"totalPage":28,"pageCount":4,"totalSize":552,"code":"91000000","status":"200"}]}}